Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Colonic Neoplasms 14 Colorectal Neoplasms 13 Neoplasms 12 Rectal Neoplasms 11 Prostatic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Uterine Cervical Neoplasms 8 Obesity 8 Motor Activity 8 Lung Neoplasms 8 Endometrial Neoplasms 8 Tobacco Use Disorder 6 Small Cell Lung Carcinoma 6 Overweight 6 Depression 6 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Leukemia, Myeloid, Acute 5 Fatigue 5 Breast Carcinoma In Situ 5 Anxiety Disorders 5 Urinary Bladder Neoplasms 4 Sexuality 4 Sexual Dysfunction, Physiological 4 Leukemia 4 Head and Neck Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Intraductal, Noninfiltrating 4 Body Weight Changes 4

Interventions

Temozolomide 159 Bevacizumab 69 Radiotherapy 68 Magnetic Resonance Spectroscopy 68 Irinotecan 31 Surgical Procedures, Operative 27 Radiation 24 Carboplatin 23 Specimen Handling 20 Carmustine 20 Blood Specimen Collection 20 Nivolumab 19 Aminolevulinic Acid 18 Biopsy 17 Lomustine 16 pembrolizumab 13 Radiotherapy, Intensity-Modulated 13 Cyclophosphamide 13 trametinib 12 fluorodopa F 18 12 X-Rays 12 Radiosurgery 12 Erlotinib Hydrochloride 12 Topotecan 11 Everolimus 11 Magnetic Resonance Imaging 10 IL13-PE38 10 dabrafenib 9 Etoposide 9 Drug Therapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Counseling × Clear all

NCT03775369 2022-05-18

Glioma and Exercising

University Hospital, Basel, Switzerland

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡